$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How to effectively deal with the side effects of upatinib treatment?
2026-02-01 22:25:32
Check Details
What dietary principles should be followed during upatinib treatment?
2026-02-01 22:25:32
Check Details
The best time to take avatrombopag (Avatrombopag, Sucoxin)
2026-02-01 22:25:32
Check Details
How long does it take for upadatinib to be effective in treating atopic dermatitis? How to take medicine?
2026-02-01 22:25:32
Check Details
Platelets do not rise after taking Avatrombopag (Avatrombopag, Su Kexin) for 5 days
2026-02-01 22:25:32
Check Details
How effective is the Laotian version of avatrombopag (Avatrombopag, Sukoxin)?
2026-02-01 22:25:32
Check Details
2025 Avatrombopag (Avatrombopag, Su Kexin) price for a box of 28 tablets
2026-02-01 22:25:32
Check Details
Platinib is a targeted drug that treats what
2026-02-01 22:25:32
Check Details
Can avatrombopag (Avatrombopag, Sucoxin) be used with immunity?
2026-02-01 22:25:32
Check Details
What diseases does Platinib target?
2026-02-01 22:25:32
Check Details
10 Tips for Taking Avatrombopag (Avatrombopag, Sucoxin)
2026-02-01 22:25:32
Check Details
Is platinib a chemotherapy drug?
2026-02-01 22:25:32
Check Details
1
2
...
1250
1251
1252
1253
1254
1255
1256
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Filgotinib: Mechanism of Action and Clinical Applications Explained
4
Lapatinib: Proper Administration Guide and Key Precautions
5
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
6
Cemiplimab Storage and Handling Guide
7
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
8
FDA Approves First mRNA Flu Vaccine mFLUSIVA
9
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
10
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
11
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
12
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring